Q2 FY27 EBITDA rises 51%; ZettaOne stake deal signed

Promoter Disclosed Acquisition PlansOrder Pipeline DisclosedInvestor Communications View source PDF Explain this filing

JUBLINGREA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.4%Reaction day

₹607.25

prior close

₹635.60

announcement price

In-mkt

timing

Nifty Smallcap 250market+2.2%+3.2% vs market

Specialty Chemicals peers, median of 100sector+1.6%+3.8% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Smallcap 250 and 3.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-2.0

15m

-1.6

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.4+2.2+3.2+1.6+3.8

Next day

-3.0pendingpending+2.0-5.0

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 revenue rose 24% to Rs 1,394 crore and EBITDA rose 51% to Rs 221 crore, with margin at 16%. Net profit increased 61% to Rs 111 crore. H1 revenue and EBITDA rose 25% and 44%. Jubilant signed a Rs 189.2 crore deal for 40% of ZettaOne, entering electronics manufacturing services.

Likely market impact

Strong results and expansion plans may support the stock, but the new acquisition, execution needs and higher input costs add risk.